Brain Thrive
Brain Thrive, licence 80089424: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- GCO PACKAGING AND MANUFACTURING LTD. dba HAVN LIFE RETAIL
- NPN or DIN-HM
- 80089424
- Status
- Active licence
- Licence date
- 4 December 2018
- Revision date
- 13 April 2022
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcuma longa - Racine | 400.0 mg | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Animaux autre que l'humain non susceptibles à l' EST - Corps pinéal | 2.0 mg | Not calculated |
| 3,4,5-Acide trihydroxybenzoïque, (2R, 3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphényl)-2H-1-benzopyrane-3-yl ester Source : Groupe de Phospholipides de Poly(phénols) de thé vert - feuille | 100.0 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut frais Extraction ratio : 50:1 Dry plant equivalent : 10000 mg Potency : 6.0 % Terpene lactones | 200.0 mg | Not calculated |
Non-medicinal ingredients
Stevia leaf, Saveur d'orange, Poudre de cacao, Saveur de cerise, Maltodextrine, Bicarbonate de potassium, Saveur de vanille, Saveur de chocolat, Acide citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Mesures | 1.0 Tous les jours |
Uses authorised in Canada
Provides antioxidants for the maintenance of good health. Helps to enhance cognitive function and memory in adults. Helps to support peripheral circulation. Source of (an) amino acid(s) involved in muscle protein synthesis. Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a healthcare practitioner prior to use if you are following a low protein diet. Consult a health care practitioner prior to use if you have a kidney disorder. May result in weight gain. Consult your health care practitioner if sleeplessness persists for more than 4 weeks (chronic insomnia). Consult a health care practitioner prior to use if you are taking medications for seizure, blood pressure, to suppress the immune system (immunosuppressive medications), to affect mental state or increase sedation or steroids. Consult a health care practitioner prior to use if you have cardiovascular, immune, hormonal or seizure disorders, asthma, depression, diabetes, low blood sugar, or migraine. Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction, or if you have stomach ulcers or excess stomach acid. Ensure to drink enough fluid before, during, and after exercise. Avoid taking with alcohol or products that increase drowsiness. If you have a liver disorder or an iron deficiency, consult a health care practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner.
Source
Official Health Canada record, licence 80089424
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.